ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Mesenchymal Stem Cells Enhance Rejection Free and Overall Islet Allograft Survival

    N. Kenyon,1 M. Willman,1 H. Dongmei,1 H. Ana,1 A. Rabassa,1 W. Diaz,1 J. Geary,1 N. Kenyon,1 A. Bartholomew,2 K. McHenry,3 D. Salomon,4 D. Berman.1

    1Surgery, University of Miami School of Medicine, Miami, FL; 2Surgery, University of Illinois at Chicago, Chicago, IL; 3National Center for Supercomputing and Analysis, University of Illinois at Urbana-Champaign, Urbana-Champaign, IL; 4Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA.

    The purpose of this study was 1) to assess the effect of mesenchymal stem cells (MSC) on intrahepatic, allogeneic islet survival in a cynomolgus monkey…
  • 2015 American Transplant Congress

    Effector T Cell Migration to Pancreatic Islet Allografts Is Dependent On Donor Antigen Recognition and Not Gαi Chemokine Signaling

    Q. Zhang, H. Dai, Q. Zeng, A. Williams, M. Oberbarnscheidt, F. Lakkis.

    Thomas E. Starzl Transplantation Institute, UPMC, Pittsburgh, PA.

    Infiltration of the graft with host effector T cells after transplantation is a key step in the pathogenesis of both acute and chronic rejection. Recent…
  • 2015 American Transplant Congress

    Outcomes of Kidney Transplantation of ABO- and Crossmatch-Incompatible Recipient-Donor Pairs Entered in Kidney Paired Donation Program

    D. Dadhania, M. Charlton, M. Aull, R. Friedlander, T. Muthukumar, J. Lee, M. Goris, D. Serur, S. Kapur, V. Sharma.

    Transplantation Medicine, Weill Cornell Medical Center, New York, NY.

    Kidney Paired Donation (KPD) enables ABO-incompatible (ABOI) and crossmatch-incompatible (XMI) patients to undergo transplantation using a 'more compatible' donor. Identification of factors that predict early…
  • 2015 American Transplant Congress

    Pre-Transplant Donor Specific Antibody With Negative Flow-Crossmatch Was Related to Higher Acute Rejection But Not to Poor Graft Survival

    A. Guichard-Romero, L. Marino-Vazquez, M. Lopez, N. Castelan, A. De-Santiago, N. Uribe-Uribe, J. Alberu, L. Morales-Buenrostro.

    Nephrology, Transplantation, and Pathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.

    Background: DSA have been associated to lower graft survival and a higher humoral rejection rate, but there is a concern about the clinical impact of…
  • 2015 American Transplant Congress

    Differential Clinical Outcomes in Kidney Transplant Recipients With De Novo C1q+ and C1q- Donor Specific Antibodies

    M. Ajaimy,1 A. Colovai,2 S. Calp,1 J. Lindower,1 M. Melamed,3 E. Akalin.1

    1Transplantation, Einstein/Montefiore Transplant Center, Bronx; 2Tissue Typing Laboratory, Einstein/Montefiore Transplant Center, Bronx; 3General Nephrology, Einstein/Montefiore Teaching Hospital, Bronx.

    Background: We investigated the prevalence and clinical significance of C1q binding versus non-C1q binding de novo DSA in kidney transplant recipients.Methods: The study group included…
  • 2015 American Transplant Congress

    The C1q-Binding Assays and Clinical Outcomes in Kidney Transplantation

    P. Amico,1 G. Hönger,1 H. Hopfer,2 R. Liwski.3

    1Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland; 2Institute for Pathology, University Hospital Basel, Basel, Switzerland; 3Department of Pathology and Laboratory Medicine, Dalhousie University, Halifax, Canada.

    Background: Contradictory conclusions have emerged from clinical trials when testing the predictive value of C1q-binding donor-specific HLA-antibodies (HLA-DSA). The aim of this study was to…
  • 2015 American Transplant Congress

    Improved Long-Term Graft Survival in Renal Transplant Recipients With Donor Specific Antibodies (DSA) After Mycophenolic Acid Escalation

    L. Rebellato,1 K. Parker,2 F. Rana,3 S. Kendrick,4 C. Morgan,5 C. Haisch,5 M. Everly,6 R. Harland,5 P. Bolin.3

    1Pathology and Laboratory Medicine, East Carolina University, Brody School of Medicine, Greenville, NC; 2Vidant Medical Center, Greenville, NC; 3Internal Medicine, East Carolina University, Brody School of Medicine, Greenville, NC; 4Eastern Nephrology Associates, Greenville, NC; 5Surgical Immunology and Transplantation, East Carolina University, Brody School of Medicine, Greenville, NC; 6Terasaki Foundation, Los Angeles, CA.

    Background: DSA formation in post-renal transplant patients is associated with chronic rejection and graft failure. Previous studies in our population indicate DSA formation is a…
  • 2015 American Transplant Congress

    Molecular Correlates of Atrophy-Fibrosis in Human Kidney Transplants Provides a New Model of Renal Fibrosis

    J. Venner, K. Famulski, P. Halloran.

    University of Alberta, Edmonton, Canada.

    We studied the effect of time post-transplant on atrophy-fibrosis (AF) and the molecular associations with AF in 703 kidney transplant indication biopsies (bx) 3 days…
  • 2015 American Transplant Congress

    Increased Cytotoxic and Regulatory T Cell and B Cell Associated Gene Transcripts in Transplant Kidney Biopsies With Non-Specific IFTA and Interstitial Inflammation

    S. Akten, M. Ajaimy, P. O Broin, Y. Bao, A. Golden, E. Akalin.

    Renal Division and Kidney Transplant Center, Computational Genomics Facility, Albert Einstein College of Medicine, Bronx, NY.

    Background: Patients with non –specific interstitial fibrosis/tubular atrophy (IFTA) have lower graft survival if their biopsies have interstitial inflammation, described as “ i” in Banff…
  • 2015 American Transplant Congress

    Impact of Elevated BMI on Allograft Outcomes: A Competing Risks Regression Analysis

    A. Naik, A. Sakhuja, M. Samaniego, P. Shrivastava, D. Cibrik.

    Section of Nephrology, University of Michigan, Ann Arbor, MI.

    INTRODUCTION: Extremes of BMI has been associated with an increased risk of death censored allograft failure. Traditionally the KM product limit estimate has been used…
  • « Previous Page
  • 1
  • …
  • 1370
  • 1371
  • 1372
  • 1373
  • 1374
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences